Skip to contentL
Longevity Health Holdings, Inc.
L
XAGELongevity Health Holdings, Inc. Q1 2025 · 10-Q
Revenue$510.35K$510.35K— vs Q1 2024 Net Income-$1.51M-$1.51MN/M vs Q1 2024 EPS Diluted-$1.52-$1.52N/M vs Q1 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Longevity Health Holdings, Inc. · CIK 1842939 · Engraved from SEC EDGAR
-$1,506,751
N/M
Operating Cash Flow-$752,953N/M Margins · derivedGross margin52.9%
Operating margin-295.2%
Net margin-295.1%
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end